Best Peptide Protocols
    Recovery / HealingSingle

    ARA-290 5mg: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for ARA-290 (16 mg Vial).

    Strength & Form:16 mg Vial
    ARA-290 (16 mg Vial) peptide vial

    ARA-290 (16 mg Vial)

    5 mg Research Peptide

    Quick Facts

    Type
    Single
    Category
    Recovery / Healing
    Vial Strength
    5 mg
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete ARA-290 5mg research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is ARA-290 5mg?

    ARA-290 5mg Vial Overview

    ARA-290 is an 11-amino acid peptide derived from erythropoietin (EPO) that selectively activates the innate repair receptor (IRR) without stimulating red blood cell production. It has been studied for neuroprotection, tissue repair, and anti-inflammatory effects. In clinical trials for sarcoidosis-related neuropathy, ARA-290 improved small nerve fiber density and reduced neuropathic pain.

    ARA-290 5mg Quick Reference

    ARA-290 5mg Vial Specifications

    Peptide
    ARA-290 (16 mg Vial) (NNMT inhibitor)
    Vial Content
    5 mg total peptide
    Category
    Recovery / Healing
    Administration Method
    Subcutaneous injection
    Common Use Case
    Neuroprotection and tissue repair without erythropoietic effects

    ARA-290 5mg Compared With Other Formats

    Details that distinguish this 5 mg format include:

    • EPO-derived without red blood cell stimulation
    • Clinical trial data for neuropathic conditions
    • Anti-inflammatory and cytoprotective properties

    How Does ARA-290 Work?

    ARA-290 Mechanism of Action

    ARA-290 is an 11-amino acid EPO derivative that selectively binds the innate repair receptor (IRR/EPOR-βcR heterodimer) without activating classical erythropoietin receptors. This produces tissue-protective and anti-inflammatory effects including neuroprotection, reduced apoptosis, and enhanced small nerve fiber repair, all without stimulating red blood cell production.

    What Are the Potential Benefits of ARA-290?

    ARA-290 Research Findings and Observed Outcomes

    Findings and reported areas of study for ARA-290 (16 mg Vial) include:

    • Neuroprotection and small nerve fiber repair
    • Anti-inflammatory cytoprotection
    • No erythropoietic activity
    • Pain reduction in neuropathic conditions

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute ARA-290 5mg?

    ARA-290 5mg Supplies for Reconstitution and Handling

    • •Insulin syringes (29–31 gauge)
    • •Bacteriostatic water
    • •Alcohol prep pads
    • •Sharps container

    Supplies listed are for laboratory handling and research preparation purposes only.

    ARA-290 5mg Administration and Research Protocol

    ARA-290 Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    FrequencyThree times weekly or daily
    TimingConsistent timing preferred

    ARA-290 5mg Dosage Guide

    ARA-290 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range1 mg per dose
    Standard Range2 mg per dose
    Upper Range2 mg per dose (50 units)

    ARA-290 5mg Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    1 mg0.25 mL25 units
    2 mg0.50 mL50 units

    This dosing table is unique to the 5 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a ARA-290 5mg Vial Last?

    ARA-290 5mg Duration by Research Dose

    At common research doses, one 5 mg vial of ARA-290 typically supports:

    1 mg per dose~5 doses
    2 mg per dose~2–3 doses
    2 mg per dose (50 units)~1 dose

    Clinical trials used 28-day protocols.

    How to Reconstitute ARA-290 5mg

    ARA-290 5mg Reconstitution With Bacteriostatic Water

    This section applies specifically to the ARA-290 (16 mg Vial).

    Recommended Diluent
    Bacteriostatic water
    Diluent Volume
    4 mL
    Final Concentration
    4 mg/mL

    ARA-290 5mg Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    ARA-290 Stacks and Research Combinations

    ARA-290 and Compatible Research Pairings

    In research settings, ARA-290 (16 mg Vial) is sometimes paired with peptides such as:

    • BPC-157: Complementary tissue repair

    Factors That May Affect ARA-290 Research Outcomes

    Supporting Factors for ARA-290 Research

    Factors recorded alongside this protocol include:

    • Neuroprotective nutrition (B vitamins, omega-3s)
    • Regular gentle exercise
    • Blood sugar management

    These factors can affect how research observations are interpreted.

    ARA-290 Side Effects and Safety Considerations

    ARA-290 5mg Tolerability Notes

    Generally well-tolerated in clinical trials.

    Some individuals report:

    • Injection site reactions
    • Mild headache

    How to Store ARA-290 Before and After Reconstitution

    ARA-290 5mg Storage Requirements

    Unreconstituted
    Refrigerate or freeze
    Reconstituted
    Refrigerate at 2–8°C
    Post-Mix Stability
    Up to 4 weeks

    Who Should Avoid ARA-290?

    This peptide is generally not recommended for:

    • Pregnant or breastfeeding individuals
    • Those with blood disorders
    • Anyone advised otherwise by a healthcare professional

    ARA-290 5mg FAQs

    Does ARA-290 increase red blood cells like EPO?

    No. ARA-290 specifically avoids erythropoietin receptor activation while retaining tissue-protective effects.

    Where to Buy ARA-290 5mg for Research

    ARA-290 5mg Purchasing and Research Supply Notes

    Before ordering ARA-290 (16 mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Recovery / Healing Peptides

    BPC-157 (5 mg Vial) productBPC-157 (5 mg Vial)BPC-157 (10 mg Vial) productBPC-157 (10 mg Vial)Cartalax (25 mg Vial) productCartalax (25 mg Vial)KPV (10 mg Vial) productKPV (10 mg Vial)LL-37 (5 mg Vial) productLL-37 (5 mg Vial)TB-500 (10 mg Vial) productTB-500 (10 mg Vial)